CNS

Venlabiox®

Brand Name:

Venlabiox®

Dosage:

37.5 mg & 75 mg

Generic Name:

Venlafaxine

Pharmacotherapeutic Group:

Antidepressant, antianxiety, antipanic agent

Therapeutic Indication:

Venlafaxine: Venlabiox is indicated for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder as defined in DSM-IV.

Dosage and Administration:

  • Generalized anxiety disorder: (extended-release capsule) initial, 37.5 to 75 mg/day ORALLY (single dose); may increase dosage by 75 mg/day every 4 days to a max dose of 225 mg/day
  • Major depressive disorder: (immediate-release tablets) outpatients, 75 mg/day ORALLY (2-3 divided doses); may increase dosage by 75 mg/day every 4 days to a max dose of 225 mg/day
  • Major depressive disorder: (immediate-release tablets) inpatients, 75 mg/day ORALLY (2-3 divided doses); may increase dosage by 75 mg/day every 4 days to a max dose of 375 mg/day (3 divided doses)
  • Major depressive disorder: (extended-release capsule) 37.5 to 75 mg/day ORALLY (single dose); may increase dosage by 75 mg/day every 4 days to a max dose of 225 mg/day
  • Panic disorder, With or without agoraphobia: (extended-release capsule) starting dose, 37.5 mg/day ORALLY for 7 days; increase dose after 1 week to 75 mg/day; subsequently, dose may be increased by 75 mg/day at weekly intervals to a MAX dose of 225 mg/day
  • Social phobia: (extended-release capsule) 75 mg/day ORALLY (single-dose)

Side Effects:

  • Cardiovascular System: hypertension
  • Digestive System: nausea, constipation, anorexia, vomiting, flatulence, weight-loss
  • Nervous System: dizziness, insomnia, dry mouth, nervousness, abnormal deams, tremor, depression, paresthesia, libido decreased, agitation
  • Urogenital System: abnormal ejaculation, impotence (male) anorgasmia (female)

Copyright © 2019 Bakhtar Bioshimi Co, All rights reserved.